Kolumne, ORE

Original-Research: Noctiluca S.A. - from East Value Research GmbH Classification of East Value Research GmbH to Noctiluca S.A. Company Name: Noctiluca S.A. ISIN: PLNCTLC00018 Reason for the research: Update from: 20.05.2024 Target price: PLN 208.90 Target price on sight of: 12-months Last rating change: Analyst: Mateusz Pudlo Noctiluca (NCL) continues to make progress in terms of both revenues from proprietary materials and the number of commercialised patented families of chemicals compounds.

20.05.2024 - 08:47:33

Original-Research: Noctiluca S.A. (von East Value Research GmbH ):


Original-Research: Noctiluca S.A. - from East Value Research GmbH 

Classification of East Value Research GmbH  to Noctiluca S.A.

Company Name: Noctiluca S.A.
ISIN: PLNCTLC00018

Reason for the research: Update
from: 20.05.2024
Target price: PLN 208.90
Target price on sight of: 12-months
Last rating change: 
Analyst: Mateusz Pudlo

Noctiluca (NCL) continues to make progress in terms of both revenues from
proprietary materials and the number of commercialised patented families of
chemicals compounds. According to management, these are two key elements in
building value for companies like Noctiluca. To date, the company has 4
patent applications, with one patent granted. NCL is becoming a recognised
company in the display industry, allowing it to convert its Material
Testing Agreements (MTAs) into paid contracts. Important Joint Development
Projects (JDPs) with two leading display companies in Korea are still
scheduled to start in H2/2024E. In addition, Noctiluca is now going one
step further from being a pure chemical company and plans to develop a
complete OLED stack with its Taiwanese partner in order to create turnkey
solutions for its customers. Noctiluca aims to be the first company in the
world to have a complete printed electronics (IJP) offering by 2024E. The
last few months have brought a lot of good news for the OLED industry,
including news of Apple's planned full implementation of OLEDs in its
tablets and laptops. Taking into account the positive development of the IP
portfolio as well as the development of the OLED industry as a whole, we
maintain our valuation of Noctiluca at USD 81.75m (PLN 325.37m / PLN 208.90
per share), which implies an upside of 97.4%.
 
In Q1/2024, Noctiluca largely completed orders from 2023, resulting in
sales of materials of PLN 272k (Q1/23: PLN 2k). Operating expenses
increased by +95.7% y-o-y to PLN 2.45m, resulting in EBITDA of PLN -1.33m
(Q1/23: PLN -1.08m) and a net income of PLN -1.81m (PLN -1.19m). At the end
of Q1/2024, NCL had only PLN 519k in cash, but thanks to a financing
agreement for a loan of up to PLN 6m with Rubicon Partners (major
shareholder of Synthex Technologies), the financial stability is ensured
until the expected share issue in H2/2024E.
 
For the full year 2024E, we have lowered our revenue estimates to PLN 4.05m
(prev. PLN 4.67m), as our decision is motivated by the postponement of
three JDP to 2025E. We now forecast an EBIT of PLN -5.22m (previously: PLN
-4.6m) and a net profit of PLN -5.19m (PLN -4.57m).

You can download the research here:
http://www.more-ir.de/d/29821.pdf
For additional information visit our website
https://eastvalueresearch.com/.

Contact for questions
Adrian Kowollik
Email:  ak@eastvalueresearch.com
Tel. +49 30 20609082

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.

@ dpa.de

Weitere Meldungen

Original-Research: Verve Group SE (von GBC AG): Kaufen Original-Research: Verve Group SE - von GBC AG Einstufung von GBC AG zu Verve Group SE Unternehmen: Verve Group SE ISIN: SE0018538068 Anlass der Studie: Researchstudie (Note) Empfehlung: Kaufen Kursziel: 6,00 EUR Letzte Ratingänderung: Analyst: Marcel Goldmann, Cosmin Filker Jun-Übernahme sorgt für deutlichen Umsatz- und Ergebniszuwachs und eine signifikante Stärkung der Demand-Side; Die Integration des Zukaufs eröffnet erhebliche Umsatzsynergien; Deutliche Erhöhung der Prognosen und des Kursziels; "Kaufen"-Rating bestätigt Am 18.06.2024 hat die Verve Group SE (Verve) die Vertragsunterzeichnung der vollständigen Übernahme der Jun Group, einem führenden Technologieunternehmen für mobile Werbung mit dem Schwerpunkt auf die Demand-Side und starke Geschäftsbeziehungen zu führenden US-Marken- und -Medienagenturen, bekanntgegeben. (Boerse, 24.06.2024 - 12:02) weiterlesen...

Original-Research: Verve Group SE (von GBC AG): BUY Original-Research: Verve Group SE - from GBC AG Classification of GBC AG to Verve Group SE Company Name: Verve Group SE ISIN: SE0018538068 Reason for the research: Research study (Note) Recommendation: BUY Target price: 6.00 EUR Last rating change: Analyst: Marcel Goldmann, Cosmin Filker Jun acquisition ensures significant sales and earnings growth and a significant strengthening of the demand side; the integration of the acquisition opens up considerable sales synergies; significant increase in forecasts and price target; 'BUY' rating confirmed On 18 June 2024, Verve Group SE (Verve) announced the signing of an agreement to fully acquire Jun Group, a leading mobile advertising technology company with a focus on the demand side and strong business relationships with leading US brands and media agencies. (Boerse, 24.06.2024 - 12:01) weiterlesen...

Original-Research: APONTIS PHARMA AG (von First Berlin Equity Research GmbH):... Original-Research: APONTIS PHARMA AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to APONTIS PHARMA AG Company Name: APONTIS PHARMA AG ISIN: DE000A3CMGM5 Reason for the research: Initiation of Coverage Recommendation: Buy from: 24.06.2024 Target price: EUR 17.00 Target price on sight of: 12 months Last rating change: - Analyst: Christian Orquera First Berlin Equity Research on 24/06/2024 initiated coverage on APONTIS PHARMA AG (ISIN: DE000A3CMGM5/ Bloomberg: APPH GR). (Boerse, 24.06.2024 - 11:01) weiterlesen...

Original-Research: Verve Group SE (von First Berlin Equity Research GmbH): Ka... Original-Research: Verve Group SE - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Verve Group SE Company Name: Verve Group SE ISIN: SE0018538068 Reason for the research: M&A Update Recommendation: Kaufen from: 24.06.2024 Target price: EUR4,90 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Verve Group SE (ISIN: SE0018538068) veröffentlicht. (Boerse, 24.06.2024 - 09:16) weiterlesen...

Original-Research: Partec AG (von Montega AG): - Original-Research: Partec AG - von Montega AG Einstufung von Montega AG zu Partec AG Unternehmen: Partec AG ISIN: DE000A3E5A34 Anlass der Studie: Suspension of Coverage Empfehlung: - seit: 21.06.2024 Kursziel: - Kursziel auf Sicht von: - Letzte Ratingänderung: - Analyst: - Coverage wird eingestellt Mit dem heutigen Tag stellen wir die Coverage der ParTec AG ein. (Boerse, 21.06.2024 - 17:01) weiterlesen...

Original-Research: Enapter AG (von First Berlin Equity Research GmbH): Buy Original-Research: Enapter AG - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Enapter AG Unternehmen: Enapter AG ISIN: DE000A255G02 Anlass der Studie: Update Empfehlung: Buy seit: 21.06.2024 Kursziel: 11,00 Euro Kursziel auf Sicht von: 12 Monate Letzte Ratingänderung: 12.08.2021: Hochstufung von Hinzufügen auf Kaufen Analyst: Dr. (Boerse, 21.06.2024 - 11:41) weiterlesen...